Pcv68 - Potential Savings in Highest Prescribing Regions for Direct-Acting Oral Anticoagulants in England

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.615
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Direct Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome

Kidney International Reports
Nephrology
2018English

Adding Herbal Products to Direct-Acting Oral Anticoagulants Can Be Fatal

European Journal of Case Reports in Internal Medicine
Internal Medicine
2019English

Direct Oral Anticoagulants (DOACs)

Vascular Medicine
MedicineCardiovascular MedicineCardiology
2015English

Direct Oral Anticoagulants: First Airbag

Medical Council
2019English

Direct Oral Anticoagulants (DOAC) in Oral Implant Surgery - A Metaanalysis

Clinical Oral Implants Research
Oral Surgery
2018English

Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know

Pharmacotherapy
Pharmacology
2017English

Reversal of Direct Oral Anticoagulants in Hemophilia Treatment

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Direct Oral Anticoagulants in Elderly Complicated, but Safe

Caring for the Ages
2017English

The Reversal of Direct Oral Anticoagulants in Animal Models

Shock
Critical CareEmergency MedicineIntensive Care Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy